Efficacy of gut-brain neuromodulators in functional esophageal disorders: a systematic review
Abstract
Background: Patients with functional esophageal disorders exhibit symptoms such as chest pain, heartburn, dysphagia, globus sensation, or reflux hypersensitivity in the absence of structural abnormalities. This is characterized by dysregulated gut-brain interactions and visceral hypersensitivity.
Methods: A systematic search of the MEDLINE, EMBASE, Web of Science and the Cochrane central register of controlled trials databases was performed to December 31, 2025. Relevant randomized controlled trials (RCT) reporting the effects of gut-brain neuromodulator (GBN) therapy on functional chest pain (FCP), functional heartburn (FH), reflux hypersensitivity (RH), functional dysphagia (FD), and globus were analyzed.
Key results: Among 2538 screened records, 29 RCTs were included. Neuromodulators provided symptom relief in 18-67% of patients with FCP, with 52-71% achieving ≥ 50% symptom reduction. Moreover, 46-80% of patients experienced a globus reduction of more than 50%. In contrast, the number of included studies for RH and FH was small, and the evidence was inconsistent. In healthy individuals, human experimental models indicated that central or local sensory-modulatory pathways can mitigate acid-induced hyperalgesia, thereby offering a promising therapeutic strategy for RH. Convincing evidence to support the use of GBN in the treatment of FD is lacking. However, its effects on normal human esophageal motility also provides strategies for drug selection, although these outcome…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.